Israel Englander’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,000
Closed -$215K 6351
2020
Q4
$215K Buy
+5,000
New +$183K ﹤0.01% 4764
2020
Q2
Sell
-10,000
Closed -$280K 4468
2020
Q1
$280K Sell
10,000
-10,000
-50% -$387K ﹤0.01% 3215
2019
Q4
$924K Buy
20,000
+10,000
+100% +$470K ﹤0.01% 3045
2019
Q3
$530K Buy
+10,000
New +$516K ﹤0.01% 3218
2019
Q2
Sell
-10,000
Closed -$564K 4348
2019
Q1
$564K Hold
10,000
﹤0.01% 3191
2018
Q4
$525K Hold
10,000
﹤0.01% 2935
2018
Q3
$578K Buy
+10,000
New +$560K ﹤0.01% 3164
2013
Q3
Sell
-20,400
Closed -$549K 3496
2013
Q2
$549K Buy
+20,400
New +$611K ﹤0.01% 2284

Other funds holding OFIX

Israel Englander's OFIX Position: Q2 2026 in Review

Israel Englander reduced its Orthofix Medical (OFIX) stake by 19% in Q2 2026, selling an estimated $2.26M and leaving 862,030 shares worth $7.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

Israel Englander first reported a position in OFIX in Q2 2013 and has held it in 47 quarters since. The position peaked at $35.7M in Q4 2017. 142 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Israel Englander held 862,030 shares of Orthofix Medical worth $7.88M as of Q2 2026.
  • Israel Englander sold 204,870 Orthofix Medical shares in Q2 2026, an estimated $2.26M.
  • Orthofix Medical made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2548 holding.
  • Israel Englander first reported a position in Orthofix Medical in Q2 2013 and has held it in 47 quarters since.
  • Israel Englander's Orthofix Medical position peaked at $35.7M in Q4 2017.
  • 142 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.